Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -1.117% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) CC(C)Cc1nc(Cl)c(C#N)c2c1CCCC2
(b) Cc1noc(C)c1CSCC(=O)Oc1ccc(N(C)S(=O)(=O)c2ccccc2)cc1
(c) Cc1nc(C)c(C(=O)OCC(=O)NCc2ccccc2)s1
(d) Cc1nnc(SCC(=O)N2CCOCC2)[nH]c1=O
Answer: d. Cc1nnc(SCC(=O)N2CCOCC2)[nH]c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nnc(SCC(=O)N2CCOCC2)[nH]c1=O
Cc1nnc(SCC(=O)N2CCOCC2)[nH]c1=O
6-methyl-3-(2-morpholin-4-yl-2-oxoethyl)sulfanyl-4H-1,2,4-triazin-5-one